• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll 样受体 4(TLR4)的序列变异与韩国男性前列腺癌的风险。

Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men.

机构信息

Advanced Urogenital Disease Research Center, Chung-Ang University College of Medicine, Seoul, South Korea.

出版信息

World J Urol. 2012 Apr;30(2):225-32. doi: 10.1007/s00345-011-0690-3. Epub 2011 May 7.

DOI:10.1007/s00345-011-0690-3
PMID:21553150
Abstract

PURPOSE

Chronic inflammation has been considered a potential risk factor for prostate cancer. Toll-like receptors (TLRs) are important in the innate immune response to pathogens and in cross talk between innate immunity and adaptive immunity. In this study, sequence variants in the TLR4 gene were investigated to determine whether they were associated with prostate cancer risk in a Korean cohort.

METHODS

An association study between 11 single-nucleotide polymorphisms (SNPs) of the TLR4 gene and prostate cancer was performed in 463 Korean male subjects including 240 prostate cancer patients and 223 healthy controls. SNPs were genotyped using the TaqMan assay, and their association with the risk of prostate cancer was evaluated using logistic regression analysis.

RESULTS

The statistical analysis revealed that one SNP at the 3'UTR (rs11536889) showed significant association with the risk of prostate cancer (P (corr) = 0.005, OR = 1.81). One common haplotype (ht2) was also significantly associated with the risk of prostate cancer (P (corr) = 0.009, OR = 1.77). However, further analysis showed no association between any of the SNPs and prostate cancer prognostic factors such as the Gleason score or tumor stage.

CONCLUSIONS

The findings of this study suggest that polymorphisms of the TLR4 gene might be associated with the risk of prostate cancer in Korean men.

摘要

目的

慢性炎症被认为是前列腺癌的一个潜在风险因素。 Toll 样受体 (TLR) 在病原体的固有免疫反应以及固有免疫与适应性免疫的相互作用中起着重要作用。在这项研究中,研究了 TLR4 基因中的序列变异,以确定它们是否与韩国队列中的前列腺癌风险相关。

方法

在包括 240 名前列腺癌患者和 223 名健康对照的 463 名韩国男性受试者中,进行了 TLR4 基因 11 个单核苷酸多态性 (SNP) 与前列腺癌的关联研究。使用 TaqMan 测定法对 SNP 进行基因分型,并使用逻辑回归分析评估其与前列腺癌风险的关联。

结果

统计分析显示,3'UTR 中的一个 SNP(rs11536889)与前列腺癌的风险显著相关(P(corr)=0.005,OR=1.81)。一个常见的单倍型(ht2)也与前列腺癌的风险显著相关(P(corr)=0.009,OR=1.77)。然而,进一步的分析表明,任何 SNP 与前列腺癌的预后因素(如 Gleason 评分或肿瘤分期)之间均无关联。

结论

本研究的结果表明,TLR4 基因的多态性可能与韩国男性前列腺癌的风险相关。

相似文献

1
Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men.Toll 样受体 4(TLR4)的序列变异与韩国男性前列腺癌的风险。
World J Urol. 2012 Apr;30(2):225-32. doi: 10.1007/s00345-011-0690-3. Epub 2011 May 7.
2
Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.Toll样受体基因簇(TLR6-TLR1-TLR10)中的序列变异与前列腺癌风险
J Natl Cancer Inst. 2005 Apr 6;97(7):525-32. doi: 10.1093/jnci/dji070.
3
Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.Toll样受体4的序列变异与前列腺癌易感性
Cancer Res. 2005 Dec 15;65(24):11771-8. doi: 10.1158/0008-5472.CAN-05-2078.
4
Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.Toll样受体4的序列变异与前列腺癌风险相关:瑞典前列腺癌研究的结果
Cancer Res. 2004 Apr 15;64(8):2918-22. doi: 10.1158/0008-5472.can-03-3280.
5
The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men.韩国男性中Toll样受体4(TLR4)基因多态性与前列腺癌风险的关联。
Cancer Genet Cytogenet. 2009 Apr 15;190(2):88-92. doi: 10.1016/j.cancergencyto.2008.12.011.
6
Pooled analysis of association between a genetic variant in the 3'-untranslated region of Toll-like receptor 4 and cancer risk.Toll样受体4 3'-非翻译区基因变异与癌症风险关联的汇总分析。
Genet Mol Res. 2015 Dec 22;14(4):17847-55. doi: 10.4238/2015.December.22.9.
7
Genetic association and functional implications of TLR4 rs1927914 polymorphism on colon cancer risk.TLR4 rs1927914 多态性与结肠癌风险的遗传关联及功能意义。
BMC Cancer. 2024 Jul 18;24(1):858. doi: 10.1186/s12885-024-12604-z.
8
Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.TLR4 基因多态性与前列腺癌的发病和死亡风险。
Prostate. 2012 Feb 1;72(2):209-16. doi: 10.1002/pros.21423. Epub 2011 May 11.
9
Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.维生素 D 受体基因多态性与韩国人群前列腺癌发病风险及进展的相关性
Gene. 2014 Jan 1;533(1):86-93. doi: 10.1016/j.gene.2013.09.119. Epub 2013 Oct 9.
10
Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.TLR4 和 TLR6-1-10 基因中的序列变异与前列腺癌风险。基于三项独立研究的汇总分析结果。
Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):873-6. doi: 10.1158/1055-9965.EPI-09-0618. Epub 2010 Mar 3.

引用本文的文献

1
MiR-135a-3p inhibits the progression of prostate cancer by targeting TLR4.微小RNA-135a-3p通过靶向Toll样受体4抑制前列腺癌进展。
Cancer Biol Ther. 2025 Dec;26(1):2545653. doi: 10.1080/15384047.2025.2545653. Epub 2025 Aug 22.
2
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity.探讨炎症小体在前列腺癌中的作用:与肥胖的相互作用。
Rev Endocr Metab Disord. 2023 Dec;24(6):1165-1187. doi: 10.1007/s11154-023-09838-w. Epub 2023 Oct 11.
3
Innate Immune Program in Formation of Tumor-Initiating Cells from Cells-of-Origin of Breast, Prostate, and Ovarian Cancers.

本文引用的文献

1
Expression of human β-defensin-2 in the prostate.人β-防御素-2 在前列腺中的表达。
BJU Int. 2011 Jan;107(1):144-9. doi: 10.1111/j.1464-410X.2010.09469.x.
2
Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.TLR4 和 TLR6-1-10 基因中的序列变异与前列腺癌风险。基于三项独立研究的汇总分析结果。
Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):873-6. doi: 10.1158/1055-9965.EPI-09-0618. Epub 2010 Mar 3.
3
Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia.
乳腺癌、前列腺癌和卵巢癌起源细胞形成肿瘤起始细胞过程中的固有免疫程序
Cancers (Basel). 2023 Jan 26;15(3):757. doi: 10.3390/cancers15030757.
4
Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.病毒进入和先天免疫的种系遗传变异可能影响 SARS-CoV-2 感染易感性:建立一种多基因风险评分以进行风险分层。
Front Immunol. 2021 Mar 8;12:653489. doi: 10.3389/fimmu.2021.653489. eCollection 2021.
5
TLR4 Polymorphisms and Expression in Solid Cancers.TLR4 多态性与实体瘤中的表达。
Mol Diagn Ther. 2018 Dec;22(6):683-702. doi: 10.1007/s40291-018-0361-9.
6
Genetic association of Toll-like receptor 4 gene and coronary artery disease in a Chinese Han population.中国汉族人群中Toll样受体4基因与冠状动脉疾病的遗传关联
Springerplus. 2016 Sep 13;5(1):1533. doi: 10.1186/s40064-016-3177-2. eCollection 2016.
7
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer.损伤相关分子模式及其相关过程在癌症中的预后和预测价值
Front Immunol. 2015 Aug 7;6:402. doi: 10.3389/fimmu.2015.00402. eCollection 2015.
8
Toll-like receptors and prostate cancer.Toll 样受体与前列腺癌。
Front Immunol. 2014 Jul 23;5:352. doi: 10.3389/fimmu.2014.00352. eCollection 2014.
9
Trial Watch: Toll-like receptor agonists in oncological indications.试验观察:肿瘤适应症中的Toll样受体激动剂
Oncoimmunology. 2014 Aug 1;3:e29179. doi: 10.4161/onci.29179. eCollection 2014.
10
Trial Watch: Toll-like receptor agonists for cancer therapy.试验观察:用于癌症治疗的 Toll 样受体激动剂
Oncoimmunology. 2013 Aug 1;2(8):e25238. doi: 10.4161/onci.25238. Epub 2013 Jun 10.
在宫颈肿瘤进展过程中,Toll 样受体 4 的表达下调。
Cancer Immunol Immunother. 2010 Jul;59(7):1021-8. doi: 10.1007/s00262-010-0825-1. Epub 2010 Feb 23.
4
Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer.Toll样受体4在前列腺中的表达及其与前列腺癌严重程度的关联。
Prostate. 2009 Sep 15;69(13):1387-97. doi: 10.1002/pros.20984.
5
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
6
The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men.韩国男性中Toll样受体4(TLR4)基因多态性与前列腺癌风险的关联。
Cancer Genet Cytogenet. 2009 Apr 15;190(2):88-92. doi: 10.1016/j.cancergencyto.2008.12.011.
7
Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.在CLUE II研究中白细胞介素10及其他免疫反应相关和肥胖相关基因与前列腺癌的关联
Prostate. 2009 Jun 1;69(8):874-85. doi: 10.1002/pros.20933.
8
Increased expression of Toll-like receptors 4 and 9 in human lung cancer.人肺癌中Toll样受体4和9的表达增加。
Mol Biol Rep. 2009 Jul;36(6):1475-81. doi: 10.1007/s11033-008-9338-9. Epub 2008 Sep 2.
9
Inflammation, infection, and prostate cancer.炎症、感染与前列腺癌。
Curr Opin Urol. 2008 May;18(3):315-9. doi: 10.1097/MOU.0b013e3282f9b3b7.
10
The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells.Toll样受体途径:感染诱导前列腺上皮细胞癌变的新机制。
Prostate. 2008 Feb 1;68(2):223-9. doi: 10.1002/pros.20710.